norfloxacin has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sivaprakash, B | 1 |
| Rajamohan, N | 1 |
| Singaramohan, D | 1 |
| Ramkumar, V | 1 |
| Elakiya, BT | 1 |
| Akyala, AI | 1 |
| Iwu, CJ | 1 |
2 other studies available for norfloxacin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Techniques for remediation of pharmaceutical pollutants using metal organic framework - Review on toxicology, applications, and mechanism.
Topics: Anti-Bacterial Agents; Carbon Fiber; COVID-19; Environmental Pollutants; Humans; Metal-Organic Frame | 2022 |
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria.
Topics: Anti-Retroviral Agents; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coinfecti | 2020 |